Sort
51,593 grants matching “hepatitis”
Efficacy of Extended Release Tramadol for Treating Prescription Opioid Withdrawal
$371,250Michelle Renee Lofwall · University Of Kentucky · R01 · FY2009 · DA
Innate Immunity, Cholesterol, and NASH Pathogenesis
$371,250Lucy Mary Golden · University Of Southern California · R01 · FY2022 · DK
Molecular mechanism of alcohol-associated liver tumor development
$371,250Shuping Zhong · University Of Southern California · R01 · FY2021 · AA
Targets of JNK in acute hepatotoxicity.
$371,250Neil Kaplowitz · University Of Southern California · R01 · FY2021 · DK
Targets of JNK in acute hepatotoxicity.
$371,250Neil Kaplowitz · University Of Southern California · R01 · FY2023 · DK
Innate Immunity, Cholesterol, and NASH Pathogenesis
$371,250Hugo R Rosen · University Of Southern California · R01 · FY2020 · DK
HIV Antiretroviral Drugs and Glucose Metabolism
$371,250Northern California Institute Res &Educ · R01 · FY2004 · DK
Liver Sinusoidal Endothelial Cell Progenitor Cells (sprocs) and Chronic Liver Disease
$371,250Laurie D Deleve · University Of Southern California · R01 · FY2022 · DK
Mechanisms of ER stress - induced fatty liver
$371,250David Thomas Rutkowski · University Of Iowa · R01 · FY2010 · DK
HIV Antiretroviral Drugs and Glucose Metabolism
$371,250Northern California Institute Res &Educ · R01 · FY2005 · DK
Multicolor Flow Users Network Study
$371,250University Of California Davis · R01 · FY2004 · AI
Innate Defense Program against HCV
$371,250Takeshi Saito · University Of Southern California · R01 · FY2019 · DK
Mechanism and in vivo anti-HBV study of a novel class of non-nucleoside compounds
$371,250Yung-Chi Cheng · Yale University · R01 · FY2007 · AI
Multicolor Flow Users Network Study
$371,250University Of California Davis · R01 · FY2003 · AI
Innate Defense Program against HCV
$371,250Takeshi Saito · University Of Southern California · R01 · FY2016 · DK
Innate Defense Program against HCV
$371,250Takeshi Saito · University Of Southern California · R01 · FY2018 · DK
NANOG-positive cancer stem cells in liver oncogenesis induced by alcohol and HCV
$371,250Keigo Machida · University Of Southern California · R01 · FY2020 · AA
Hepatitis C virus and autophagic response
$371,250J.-H. James Ou · University Of Southern California · R01 · FY2020 · DK
Molecular mechanism of alcohol-associated liver tumor development
$371,250Shuping Zhong · University Of Southern California · R01 · FY2019 · AA
Regulation of factor VIII Levels and Activity by Members of LDL Receptor Family
$371,250Dudley K. Strickland · University Of Maryland Baltimore · R01 · FY2012 · HL
NANOG-positive cancer stem cells in liver oncogenesis induced by alcohol and HCV
$371,250Keigo Machida · University Of Southern California · R01 · FY2017 · AA
NANOG-positive cancer stem cells in liver oncogenesis induced by alcohol and HCV
$371,250Keigo Machida · University Of Southern California · R01 · FY2021 · AA
Innate Immunity, Cholesterol, and NASH Pathogenesis
$371,250Hugo R Rosen · University Of Southern California · R01 · FY2021 · DK
Molecular mechanism of alcohol-associated liver tumor development
$371,250Shuping Zhong · University Of Southern California · R01 · FY2017 · AA
Liver Sinusoidal Endothelial Cell Progenitor Cells (sprocs) and Chronic Liver Disease
$371,250Laurie D Deleve · University Of Southern California · R01 · FY2020 · DK